Back

Short-term effects of SGLT2 inhibitors on myocardial extracellular volume, left ventricular function and inflammation in patients with HFpEF and diabetes mellitus

29 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Approaches to declining ejection fraction Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Anastasios Marathonitis

Sotiria Thoracic Diseases Hospital of Athens, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Dose titration among patients receiving vericiguat in real-world clinical practice and association with clinical outcomes and health care resource use
Doctor A. Ambrosy (San Francisco, US)
Abstract Slides Video
Presentation thumbnail
Guideline-directed medication therapy use among patients with HFrEF receiving vericiguat: comparing findings from a real-world study to clinical trials
Doctor A. Ambrosy (San Francisco, US)
Abstract Slides Video
Presentation thumbnail
Impact of comprehensive heart failure management initiated during hospitalization on clinical outcomes in patients with decompensated heart failure with reduced ejection fraction
Associate Professor R. Christodorescu (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
Residual risk of hospitalization & all-cause mortality among patients with heart failure with reduced ejection fraction without worsening heart failure who received guideline-directed medical therapy
Doctor A. Stevenson (Chatham, US)
Abstract Slides Video
Presentation thumbnail
Cardiac cGMP augmentation and hemodynamic improvement in heart failure with reduced ejection fraction: evidence from sacubitril/valsartan and vericiguat treatment
Doctor T. Inoue (Sendai, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Approaches to declining ejection fraction

The Event

Event poster

ESC Congress 2025

29 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of sodium-glucose cotransporter-2 inhibitors on left ventricular-arterial coupling and myocardial extracellular volume in patients with type 2 diabetes mellitus and HFpEF
thumbnail
Congress Presentation
The effects of SGLT2 inhibitors in patients with preserved ejection fraction heart failure and type 2 diabetes: A randomized case-control study
thumbnail
Congress Presentation
Effect of sodium-glucose type 2 cotransporter inhibitors on cardiac structure and function in patients with normal ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources